The First Targeted Therapy to Treat Cancer: The Tamoxifen Tale-Reference-Cited by-同舟云学术

The First Targeted Therapy to Treat Cancer: The Tamoxifen Tale

Published:2018-10-17 Issue: Volume: Page:151-188
ISSN:2196-9906
Container-title:Estrogen Receptor and Breast Cancer
language:
Short-container-title:

Author:

Abderrahman Balkees,Jordan V. Craig

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-99350-8_7

Reference143 articles.

1. Lerner LJ, Holthaus FJ Jr, Thompson CR (1958) A non-steroidal estrogen antagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol. Endocrinology 63(3):295–318. https://doi.org/10.1210/endo-63-3-295

2. Lerner LJ, Jordan VC (1990) Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. Cancer Res 50(14):4177–4189

3. Segal SJ, Nelson WO (1958) An orally active compound with anti-fertility effects in rats. Proc Soc Exp Biol Med 98(2):431–436

4. Emmens CW, Cox RI, Martin L (1962) Antioestrogens. Recent Prog Horm Res 18:415

5. Holtkamp DE, Greslin JG, Root CA, Lerner LJ (1960) Gonadotrophin inhibiting and anti-fecundity effects of chloramiphene. Proc Soc Exp Biol Med 105:197–201

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional coactivator MED1 in the interface of anti-estrogen and anti-HER2 therapeutic resistance;Cancer Drug Resistance;2022

2. Modification of WS2 nanosheets with beta-cyclodextrone and N-isopropylacrylamide polymers for tamoxifen adsorption and investigation of in vitro drug release;Research on Chemical Intermediates;2021-01-05

3. Estrogen receptor coactivator Mediator Subunit 1 (MED1) as a tissue-specific therapeutic target in breast cancer;Journal of Zhejiang University-SCIENCE B;2019-05